Logan Lutton's profile photo

Logan Lutton

Brooklyn

Associate Editor, MJH Associates Inc at Physicians Practice

Associate Editor at Managed Healthcare Executive

Featured in: Favicon physicianspractice.com Favicon psychiatrictimes.com Favicon contemporaryobgyn.net Favicon medicaleconomics.com Favicon dermatologytimes.com Favicon patientcareonline.com Favicon drugtopics.com Favicon urologytimes.com Favicon conciergemedicinetoday.org Favicon newsbreak.com

Articles

  • MHE Week in Review – CEOs Defend their PBMs, Medicaid Likely Target and More

    1 week ago | managedhealthcareexecutive.com | Logan Lutton

    Each Sunday we feature a highlight reel of various articles posted on our website that week. We’ll be back on Monday morning with more fresh content!

  • FDA Approves First Prophylactic Therapy for Hemophilia A or B With or Without Inhibitors

    1 week ago | managedhealthcareexecutive.com | Logan Lutton

    The FDA has approved Sanofi’s Qfitlia (fitusiran) as the first therapy in the United States to treat hemophilia A or B with or without inhibitors for patients ages 12 and older, according to a news release.

  • Pharmaceutical Market Trend Insight, Experts Talk GLP-1 Competition and More | AMCP Annual 2025

    2 weeks ago | managedhealthcareexecutive.com | Logan Lutton

    More than 4,000 managed care pharmacy professionals attended the 2025 Academy of Managed Care Pharmacy (AMCP) conference held last week in Houston. In the crowd were Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, and Doug Long, MBA, vice president of industry relations at IQVIA.

  • ART Resistance Associated with Higher Hospital Costs Despite Lower Pharmacy-Related Expenses | AMCP Annual 2025

    2 weeks ago | managedhealthcareexecutive.com | Logan Lutton

    United States military veterans with antiretroviral therapy (ART) resistance cost more when it comes to healthcare resource utilization, according to a new study that found 26.6% of veterans with resistance were hospitalized for HIV-related complications when compared to veterans with no resistance, 21.3% of whom were hospitalized. However, pharmacy costs for both cohorts were similar, with HIV-specific costs higher in the group with no ART resistance.

  • Stool Test Could Improve TB Detection in HIV Patients, Study Shows

    2 weeks ago | managedhealthcareexecutive.com | Logan Lutton

    Testing HIV patients’ stool for tuberculosis (TB) may become an additional method for detecting TB, according to research recently published in The Lancet Microbe. Additionally, the test results show that using a stool sample resulted in a 45% TB detection rate in HIV patients with CD4 counts below 200 cells per cubic millimeter (200 cells/μl)—one of the criteria for an AIDS diagnosis. The TB test used was Xpert MTB/Ultra, a molecular diagnostic test that traditionally relies on sputum samples.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →